Characteristics and comorbidities of veterans treated with enzalutamide or abiraterone.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2021.39.15_suppl.e17022
Abstract: e17022 Background: Prostate cancer (PCa) is the most common male malignancy and is the fourth leading cause of cancer-related death in males worldwide. Enzalutamide (ENZ) and Abiraterone (AA) are used in the treatment of castrate… read more here.
Keywords: patients treated; treated enz; treatment; characteristics comorbidities ... See more keywords